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Fetal adenocarcinoma — a rare variant of lung  
adenocarcinoma with good prognosis
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Barbara Burakowska4, Kazimierz Roszkowski-Śliż1
Fetal adenocarcinoma (FA) is a rare variant of lung adenocarcinoma with a good prognosis which represents approxi-
mately 0.5% of all primary lung neoplasms. The tumour has nonciliated tubules with morules in the lumen resembling 
fetal lung at 10 to 16 weeks of gestation. FA typically occurs in young patients 75–80% of whom are tobacco smok-
ers. FA occurs in low- and high-grade forms. Surgical procedure is usually necessary to obtain final diagnosis and  
a complete surgical resection is the standard treatment. The 5-year survival rate for FA is about 75–80%. We report  
a case of 32-year-old male, a smoker, who had an incomplete regression of parenchymal consolidations after antibiotic 
treatment, which led to further diagnostics. An intravenous tumour in one of the pulmonary veins with concomitant 
development of collateral circulation and pulmonary venous infarction were additional diagnostic problems. Based 
on the intraoperative microscopic examination, fetal adenocarcinoma was diagnosed. An upper right bilobectomy 
with intrapericardial ligation of the right superior pulmonary vein was performed as radical treatment. At the 9-month 
follow-up stage, there has been no evidence of disease recurrence.
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Introduction 
Fetal adenocarcinoma (FA) occurs very rarely, accounting 
for only about 0.1–0.5% of all primary lung neoplasms [1, 2]. 
Its architecture is made up of tubules consisting of noncili-
ated cells rich in glycogen, resembling fetal lungs at 10 to 
16 weeks of gestation [2, 3]. Within the lumen of the tubules, 
there are the so-called morules made up of the cells with 
squamous differentiation. The presence of characteristic 
extranuclear vacuoles, rich in glycogen, makes adenocar-
cinoma resemble uteral mucosa in the secretion phase [4]. 
The specific feature of this carcinoma is the presence of 
argyrophil cells with neurosecretion activity [5, 6].
In 1982 Kradin et al. described the “pulmonary form of 
blastoma” containing in its architecture, argyrophil cells 
without sarcomatous features defining it as an endoder-
mal lung tumour which resembles a fetal lung. Koss et al., 
analysing 52 lung blastoma cases distinguished its form 
lacking sarcomatous features, which later on was named 
a well-differentiated fetal adenocarcinoma. Its idiosyncratic 
feature, differentiating it from other blastoma forms, was 
a much better prognosis. According to the WHO tumour 
classification, since 1999 fetal adenocarcinoma has been 
considered as a histological variant of adenocarcinoma [2, 7]. 
Within a group of fetal adenocarcinomas, two groups of 
tumours have been distinguished: a well-differentiated form 
with a low-grade malignancy and a poorly-differentiated 
form with a high-grade malignancy. Fetal adenocarcinoma 
with a low-grade malignancy usually affects young people, 
mostly women with a moderate cigarette smoking history. 
The histopathological evaluation of this type of cancer re-
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veals a small atypia of cellular nuclei and a tendency to 
create morules, as opposed to a less differentiated form. 
The disease is usually diagnosed at stage I and the mortality 
rate is about 10%. The form with a high-grade malignancy 
usually affects patients a few decades later, concerning 
men with a long cigarette smoking history more often. The 
microscopic examination reveals a generalised disorganisa-
tion of glands, necrosis, cellular atypia and morules are quite 
rare. This tumour resembles more a typical lung adenocar-
cinoma and a component of other morphological subtypes 
of adenoma is more frequently found. This disease tends to 
be diagnosed at a more advanced stage, which results in 
a higher mortality rate [8, 9]. 
Although the pathogenesis of fetal adenocarcinoma 
remains unclear, in patients with a low malignancy degree 
form, the mutation of the p53 with the p53 protein hyper-
expression related to this mutation was found. Nakatani 
et al. also detected some incorrect nuclear-cytoplasmatic 
b-catenin expression, which led them to a hypothesis that 
b-catenin mutation is involved in the proliferation of epi-
thelial cells and the creation of morules [8, 10, 11]. The ob-
servation of children suffering from fetal adenocarcinoma 
show that this can be the rare form of DICER1 syndrome 
connected with somatic mutation or the mutation from 
the line of germinal cells [12]. Fetal adenocarcinoma with 
a high malignancy degree is not strongly connected with 
any genetic mutation.
The prognosis of patients with fetal adenocarcinoma, in 
comparison with more frequent forms of adenocarcinoma or 
fetal carcinoma, is good. It depends, first of all, on the grade 
of malignancy and the advancement stage of the cancer. 
In a group of patients with fetal adenocarcinoma with 
a low malignancy degree, the 5-year survival rate is 75–80%, 
whilst in a group of patients in the stage I of advancement it 
reaches even 90% [1, 6–8, 10]. Poor prognosis is associated 
with the presence mediastinal lymphadenopathy, initial 
metastases and disease recurrence after treatment [13]. 
In the patients with a diagnose of a poorly differentiated 
form of this tumour, with a high-grade of malignancy, the 
prognosis depends also on morphological components of 
the adenocarcinoma which are present in the architecture 
of fetal adenocarcinoma [5].
This article presents the case of a young male patient, 
a cigarette smoker, in whose case the diagnostics of resistant 
parenchymal lesions in the lungs after an infection led to 
a diagnosis of fetal adenocarcinoma. 
Case report 
A 32-year-old male with a cigarette smoking history 
(7 smoking pack-years) was referred to the Institute of Tuber-
culosis and Lung Diseases with a suspicion of staphylococcal 
pneumonia. The disease began one month and a half before 
the admission to the Institute with the following symptoms: 
high fever, cough, haemoptysis and a strong pain in the right 
side of the chest. The patient was admitted to his regional 
hospital. Additional examinations revealed increased inflam-
mation markers, such as leucocytosis — 11 thousand/mL 
with an increased neutrophil count (8.49 thousand/mL and 
increased CRP levels 172.59 mg/L. The chest X-ray revealed 
diffuse opacities in the right upper lobe with a right hilum en-
largement and a pleural reaction. Treatment with amoxicillin 
with clavulanic acid was initiated, resulting in an alleviation of 
high fever and pain within a few days. Additional follow-up 
tests revealed the normalisation of leucocytosis and a de-
crease of CRP levels (48.81 mg/L). The patient was discharged 
home with the recommendation to continue antibiotics and 
perform a follow-up chest X-ray in two weeks.
The follow-up chest X ray revealed a 44 × 30 mm tumor 
in the right upper lobe with concomitant atelectasis. To ex-
tend the diagnosis a chest computed tomography was per-
formed. In the right upper lobe it revealed the consolidated 
parenchymal lesions with irregular margins abutting the pa-
rietal pleura and oblique interlobar fissure with a visible air 
bronchogram, surrounded by ground glass opacities. More-
over, in segment 3, some nodular tumour-like lesions were 
detected with contrast enhancement up to 57 Hounsfield 
Units (HU) with an enlargement of the lymph nodes of the 
right hilum. The largest tumour-like lesion was 44 × 33 mm, 
whilst the smaller ones were about 10 mm. On the basis 
of the CT scan of the chest, a suspicion of staphylococcal 
pneumonia was made and the patient was urgently referred 
to the Institute of Tuberculosis.
Upon admission, the patient was in a good general con-
dition, with some chest discomfort during deep breathing 
and a slight cough. Additional lab tests were unremarkable: 
the inflammation markers were no longer elevated and the 
D-dimer and LDH serum levels were normal. The chest X-ray 
revealed inhomogeneous patchy parenchymal densities in 
the right upper lobe with enlargement of the right hilum 
caused by a round lesion with a diameter of 18 mm (Fig. 1). 
During the consultations of the submitted chest CT scans 
with radiology specialists, it was found that the above-
described spherical mass filled the lumen of the superior 
pulmonary vein and the confluent densities correspond to 
pulmonary infraction. The echocardiography did not reveal 
any right ventricular overload or pulmonary hypertension. 
However, in the area of the right pulmonary venous drain-
age, it revealed some additional irregular echoes with a 
diameter up to 40 mm, which were likely to press/infiltrate 
the right pulmonary veins and pericardium. Anticoagu-
lants (LMWH) were introduced (a history of haemoptysis) in 
gradually increasing doses. With regards to the fact that the 
degree of intraluminal contrast filling in the submitted CT 
scan did not allow for a reliable evaluation of the relationship 
between the nodular-tumour-like lesions and the vessels, 
the examination was repeated with a angio-CT option. In the 
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upper pole of the right hilum, a tumor, measuring 28 × 22 mm 
was revealed — it was located within the right superior 
pulmonary vein, extending proximally in the direction of the 
left atrium and ending 10 mm from the outlet of the vein. 
The infiltration was extending distally in the dilated veins of 
segment 3, making up large tumour-like forms, measuring 
30 × 35 mm. Within these visible lesions, there were thin ves-
sels with marginal enhancement which could correspond to 
collateral circulation. Moreover, in segments 1 and 2 there 
were parenchymal densities, which could correspond to 
pulmonary infarction, a little smaller when compared to the 
examination made 10 days before (Figs. 2, 3). A hypothesis 
of the proliferative process was made, taking into considera-
tion, first of all, angiosarcoma or leiomyosarcoma.
The location of the lesion within the lumen of the pul-
monary veins with an extensive collateral circulation led to 
an idea to abandon the previously planned transthoracic 
fine-needle aspiration biopsy (TFNAB). After consulting 
a thoracic surgeon, the patient was qualified for surgery 
with intraoperative microscopic assessment of the surgical 
material. After two weeks of anticoagulation treatment, 
the patient underwent an antero-lateral thoracotomy with 
a resection of the fragment of lung parenchyma with a well- 
-defined soft hyaline tumour, size: 3.4 × 3.7 cm, white-
greyish in colour with some satellite foci (Fig. 4). The intra-
operative microscopic assessment of the tumour revealed 
a malignant tumour of the epithelial cells with necrosis. It was 
intraoperatively assessed that radical surgery was possible 
and thus a right upper bilobectomy was performed with 
intrapericardial ligation of the right superior pulmonary 
vein with lymphadenectomy.
Analysis of the post-operative specimen allowed an 
ultimate diagnosis of fetal adenocarcinoma with diffuse 
areas with a low (and focally high) degree of malignancy. 
Mucicarmine staining of the mucosal staining rendered 
negative result. In the immunohistochemistry tests, cy-
tokeratin expression was found with a wide spectrum of 
(CKAE1/AE3), TTF-1, b-catenin, synaptophysin focally and 
< 10 % CK7 cells, whilst chromogranin A and vimentin were 
negative (Figs. 5, 6). 
No tumor infiltration was found in the surgical margin of 
the bronchi and in the vessels and no metastases were found 
in the harvested fragments of the lymph nodes of the 11, 7, 
Figure 1. Chest X-ray: Patchy parenchymal densities, peripherally in 
the right upper lobe with right hilum enlargement caused by a round 
lesion with a diameter of 18 mm
Figure 2. CT scan, pulmonary window: A polycyclic tumor and a few 
smaller nodules with smooth margins in the anterior segment of the 
right upper lobe and subpleural parenchymal density corresponding 
to a lung infarction in the posterior segment of this lobe
Figure 3. CT scan, mediastinal window, MIP reconstruction: tissue 
masses obliterating the dilated proximal segment of the right 
superior pulmonary vein, corresponding to an intravascular tumour 
mass. Small dilated collateral vessels within the hilum
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4R and 10R group. The final diagnosis was adenocarcinoma 
fetale pulmonis dextri high-grade (pT3N0R0L0V1) with IIB ad-
vancement stage. The postoperative course was uneventful. 
Given the diagnosis of a fetal adenocarcinoma which 
usually has a good prognosis, and the radical type of surgery, 
which is the treatment of choice in this type of carcinoma 
as well as some equivocal recommendations concerning 
adjuvant treatment, the idea of adjuvant chemotherapy 
was abandoned. Nevertheless, after the discharge, the pa-
tient contacted another centre, where he received 4 cycles 
of chemotherapy based on cisplatin and etoposide. The 
patient remained under the supervision of an oncological 
and a thoracic-surgery clinic for 9 months. The follow-up 
chest computed tomography did not reveal any prolifera-
tive processes. 
Discussion
The case of the presented patient shows that unusual 
complaints of the respiratory tract, paired with unremark-
able results of blood laboratory tests should not be an ar-
gument against a thorough diagnostic process, being an 
indication at the very least for a chest X-ray. The described 
case encourages a broader look at the patient with ad-
enocarcinoma. The diagnosis of fetal adenocarcinoma, in 
comparison with other lung adenocarcinomas, is usually 
connected with good prognosis, which, given the young 
average age of the subjects may have a significant influence 
factor on their planning of the future. 
This paper describes a case of a 32-year old male patient 
with a cigarette smoking history, in whose case the results 
of a thorough diagnostic process led to a diagnosis of fetal 
adenocarcinoma. The average age of patients, at the mo-
ment of diagnosis, is the 4th decade of life, so the majority of 
patients are young people, prevalently cigarette smokers [9, 
10, 14]. The disease frequently is asymptomatic, with tumour-
like lesions in the lungs which are found accidentally during 
periodical medical check-ups [2, 9]. The symptoms of fetal ad-
enocarcinoma, once they occur, are not typical and comprise: 
dry cough, fever, debilitation and fatigue. The more worry-
ing symptoms are haemoptysis and chest pain [2, 3, 7, 13, 
15–17]. One of the rare causes of chest pain is the pres-
ence of fluid in the pleural cavity caused by its involvement 
with cancer, or secondary lesions connected with emboli in 
the pulmonary vessels accompanying the adenocarcino- 
ma [15, 18]. The patient, whose case is discussed here, reported 
mainly a cough and chest pain. During outpatient treatment, 
he also experienced some haemoptysis. In his chest X-ray, the 
atelectasis of the right upper lobe was found with a smooth-
Figure 6. The fragments of fetal adenocarcinoma with the presence 
of morules (arrow). HE staining (A); Immunohistochemistry assay with 
TTF-1 antibody. A positive reaction within the cancer cells is visible. 
Large magnification (B)
Figure 4. A lung with a visible tumour with a smooth, shiny surface, 
filling the lumen of a large branch of the pulmonary vein (red arrow)
Figure. 5. Microscopic evaluation of lung tumour specimen. The 
architecture of fetal adenocarcinoma with irregular tubules (A), lined 
with glandular epithelium with clear cytoplasm (B). Small and large 
magnification, HE staining
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-contoured tumor, measuring 44 × 30 mm. The abnormalities 
in the chest X-ray of such patients, which usually reveal at-
electasis or a well-defined tumor, usually make up about 76% 
cases. The lesions tend to be situated in the right lung, and, in 
particular, similarly as in the case of the presented patient, in 
the upper lobe [2, 10, 15]. The chest computed tomography 
usually reveals a well-defined tumour mass with an average 
size of 3.5–4.5 cm. The numerous nodular tumour-like lesions 
and intra-bronchial lesions are quite infrequent, and the 
involvement of the lymph nodes or the pleural cavity is ra- 
re [2, 10]. In some patients, a chest computed tomography re-
veals, apart from oncological lesions, lesions corresponding to 
a pulmonary infarction [6]. The cause of these lesions might 
by the thromboembolism accompanying the cancer, or, as 
was the case here, such lesions were the result of the impo-
tency of the pulmonary vessels obstructed by the tumour 
mass. The computed tomography of this patient’s chest re-
vealed a tumour of the right hilum, measuring 28 × 22 mm, 
located within the right superior pulmonary vein extending 
proximally towards the left atrium. The infiltration was ex-
tending distally in the dilated veins of segment 3, making up 
large tumour-like forms, measuring 30 × 35 mm. Moreover, in 
segments 1 and 2, there were parenchymal densities, which 
could correspond to pulmonary infarction. No description of 
adenocarcinoma of the lung, involving pulmonary vessels, 
has been found in available publications.
In the discussed case the diagnosis was made on the 
basis of a intraoperative microscopic assessment. The loca-
tion of the lesions and their unclear type led to giving up 
the idea of the previously planned CT-guided transthoracic 
fine-needle aspiration biopsy (TFNAB).
Preoperative assessment of the specimen collected 
with a bronchoalveolar brush or transthoracic fine needle 
aspiration biopsy (TFNAB) usually allows a hypothesis of 
a neuroendocrine tumour to be made. The final diagnosis, 
similarly as in this case, is possible only after a surgery and 
a microscopic assessment of the resected tumour.
The treatment of choice is surgery — the resection of 
the lobe with the tumour connected with the lymphadenec-
tomy. In the discussed case, with regards to the location of 
the tumour and its extensity, a right upper bilobectomy was 
performed with intrapericardial ligation of the right superior 
pulmonary vein and with a mediastinal lymphadenectomy. 
Fetal adenocarcinoma is still a rare disease, so the collec-
tion of a representative group of patients in order to define 
treatment standards remains impossible. Even though there 
are reports about the benefits in adjuvant chemotherapy 
and radiotherapy, these are not recommended treatments. 
The largest number of cases with equivocal results concern 
the administration of adjuvant chemotherapy containing 
cisplatin with etoposide [1, 16, 17]. 
The prognosis of patients with fetal adenocarcinoma 
is usually good. The presented patient remained under the 
supervision of an oncological and a thoracic-surgery clinic 
for 9 months with follow-up chest computed tomography 
not revealing any proliferative processes. 
The above article discussed a case of a rare variant of 
histological lung adenocarcinoma — a fetal adenocarci-
noma. What makes this case quite unique is the fact that the 
changes were located within the pulmonary veins, which 
posed an additional diagnostic and treatment problem.
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